Eloxx Pharmaceuticals ELOX
NASDAQ ELOX
$13.01 +0.11 (+0.85%)
At close: Nov 11, 2026 · 4:00 PM EST

Eloxx Pharmaceuticals (ELOX) Return on Sales [ROS] (2009 - 2015)

Updated

Eloxx Pharmaceuticals (ELOX) recorded Return on Sales [ROS] of -38.81% in FY2024.

Analysis

Eloxx Pharmaceuticals (ELOX) Return on Sales [ROS] (2009 - 2015) Analysis & Trends

Starting with FY2010, Eloxx Pharmaceuticals' Return on Sales [ROS] history includes 5 years.

  • The FY2024 figure is the highest annual Return on Sales [ROS] in data going back to FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Eloxx Pharmaceuticals 87.58 Mn 13.90 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 -6,201,918.66%
Mar 31, 2015 -611,353.46%
Dec 31, 2014 -1,080,112.76%
Sep 30, 2014 -290,509.36%
Jun 30, 2014 -135,790.88%
Sep 30, 2012 -3,239.13%
Jun 30, 2012 -3,193.41%
Mar 31, 2012 -4,705.64%
Dec 31, 2011 -728.07%
Jun 30, 2011 -520.91%
Mar 31, 2011 -444.96%
Dec 31, 2010 -425.02%
Sep 30, 2010 -138.70%
Jun 30, 2010 -309.71%
Mar 31, 2010 -274.39%
Dec 31, 2009 -723.54%
Sep 30, 2009 -67.84%
Jun 30, 2009 -1,558.18%
Mar 31, 2009 -1,330.32%
API Access

Eloxx Pharmaceuticals Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ELOX&period=max&api_key=YOUR_API_KEY